<DOC>
	<DOCNO>NCT02605512</DOCNO>
	<brief_summary>Breast radiotherapy RT use 1990s clearly responsible increase mortality due long term cardiac complication . Since 2000s , improvement appear dose distribution organ risk heart , , little know risk potential cardiac impairment population , particular chemotherapy naive patient . Based state clinically detectable cardiotoxicity generally precede subclinical cardiac dysfunction , aim BACCARAT study ( BreAst Cancer Cardiotoxicity induce RAdioTherapy ) evaluate whether adjuvant 3DCRT induces cardiac toxicity could detect first two year treatment base global approach repeat analysis subclinical functional anatomical cardiac lesion myocardial coronary level circulate biomarkers .</brief_summary>
	<brief_title>BreAst Cancer Cardiotoxicity Induced RAdioTherapy : BACCARAT Study</brief_title>
	<detailed_description>BACCARAT study consist monocentric prospective cohort study finally include 120 woman treat adjuvant RT breast cancer Clinique Pasteur Toulouse , follow 2 year RT . Women age 50 70 year , treat breast cancer adjuvant 3DCRT indicated , without chemotherapy eligible study . Baseline follow-up include measure functional myocardial dysfunction base 2D-speckle tracking echocardiography , anatomical coronary lesion base Coronary compute tomography angiography , wide panel circulate biomarkers . Absorbed dose evaluate whole heart different part heart , particular coronary artery . Analysis occurrence evolution subclinical cardiac lesion biomarkers perform complete dose-response relation absorb dos different heart segment .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>Age 50 70 year Women surgically treat leave right breast cancer adjuvant treatment radiotherapy irradiation breast chest wall irradiation possibly ganglion chain , Adjuvant radiotherapy 3DCRT performed Clinique Pasteur Toulouse WHO performance status ECOG Eastern Cooperative Oncology Group ( index normally use describe patient 's condition ) = 0 1 Being volunteer participate study sign consent form Indication adjuvant chemotherapy Clinically radiologically detectable metastasis Personal history coronary artery disease myocardial disease Personal history breast cancer cancer require radiotherapy thorax Patient control infection severe disease / nonhazardous participation study Contraindications injection iodinate contrast ( CCTA ) : pregnancy , renal failure , allergy . Pregnancy , lactation Abnormal echocardiography radiotherapy : LVEF &lt; 50 % Longitudinal strain &gt; 16 % Longitudinal strain rate &lt; 1 % / Abnormal wall motion CCTA radiotherapy show therapeutic management require ( coronaryartery calcium ( CAC ) score &gt; 600 )</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Strain strain rate</keyword>
	<keyword>Coronary compute tomography angiography</keyword>
	<keyword>Segments coronary artery</keyword>
	<keyword>Subclinical functional anatomical cardiac lesion</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Heart dosimetry</keyword>
</DOC>